Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

64 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Sale
128,985$32.36$4.2M123,127(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Sale
1,274$32.36$41.2K2,926(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Sale
442,935$32.36$14.3M1,121,382(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Sale
80,762$32.36$2.6M85,616(D)

View →

Mar 4, 2026Mar 4 10:42 PMFox Christine
Proposed Sale
9,908$32.46$321.7K

View →

Mar 4, 2026Mar 4 10:36 PMFrancis Richard D
Proposed Sale
23,393$32.46$759.4K

View →

Mar 4, 2026Mar 4 10:28 PMHughes Eric A
Proposed Sale
11,277$32.46$366.1K

View →

Mar 4, 2026Mar 4 10:22 PMDaniell Richard
Proposed Sale
91,345$32.66$3.0M

View →

Mar 3, 2026Mar 3 10:46 PMSavage Brian
Proposed Sale
1,274$32.36$41.2K

View →

Mar 3, 2026Mar 3 10:34 PMFrancis Richard D
Proposed Sale
442,935$32.36$14.3M

View →

Mar 3, 2026Mar 3 10:25 PMHughes Eric A
Proposed Sale
80,762$32.36$2.6M

View →

Mar 3, 2026Mar 3 10:13 PMDaniell Richard
Proposed Sale
128,985$32.36$4.2M

View →

Feb 26, 2026Mar 2 9:01 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Sale
345,810$33.64$11.6M57,478(D)

View →

Feb 26, 2026Feb 26 9:11 PMKalif Eliyahu Sharon
Proposed Sale
345,810$33.64$11.6M

View →

Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Sale
447,778$34.22$15.3M605,771(D)

View →

Feb 17, 2026Feb 18 11:28 AMFrancis Richard D
Proposed Sale
447,778$34.22$15.3M

View →

Feb 17, 2026Feb 18 11:12 AMFrancis Richard D
Proposed Sale
447,778$1.00$447.8K

View →

Dec 12, 2025Dec 12 9:17 PMBridger Management, LLC (1)
Proposed Sale
150,000$30.18$4.5M

View →

Dec 9, 2025Dec 9 9:03 PMSabag Mark
Proposed Sale
216,892$28.73$6.2M

View →

Dec 9, 2025Dec 9 9:00 PMDaniell Richard
Proposed Sale
115,468$28.68$3.3M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 27, 2026Jan 29 9:04 PMMark SabagSee "Remarks"
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:02 PMRichard DaniellExec. VP, European Commercial
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:01 PMRichard D FrancisPresident and CEO
Grant/Award
1,511,425891,315(D)

View →

← Previous

Page 4 of 4